News
15 January 2026
Rutgers & Posch advises Engius
Rutgers & Posch advises Engius (a portfolio company of Green Park Investment Partners) on its acquisition of De Verenigde Expertise Groep and the reinvestment by the seller. De Verenigde Expertise Groep is a Dutch group that specialises in performing damage assessments, preliminary recordings, vibration measurements, deformation measurements and technical investigations. The Rutgers & Posch team consisted of Bas Mees, Joost Kuipers and Manouk van Riele.
Read more >8 January 2026
Rutgers & Posch advises Anders Invest
Rutgers & Posch advises Anders Invest on the acquisition of an equity stake in Straatman Building Smart Connections and the reinvestment by the current shareholders. Straatman Building Smart Connections is a manufacturer of balcony railings and balustrades and has an annual turnover of €20 to €25 million and nearly 100 employees. Anders Invest is an investment fund that primarily invests for the long term in Dutch manufacturing companies,…
Read more >17 December 2025
Rutgers & Posch advises Colbe on the acquisition of Aquilum group from Karmijn Kapitaal
Rutgers & Posch advises its longstanding client Colbe (formerly known as Zorg van de Zaak), a portfolio company of Parcom, on the acquisition of Aquilum group, a specialist in sustainable employability. The transaction is still subject to approval by relevant regulatory authorities. The Rutgers & Posch team consisted of Matthijs van den Broek, Justus Fortuyn, Veerle Cordemeijer, Laura Dingemans, Jeanne Plettenburg, Hanna Steensma, Ilaha Muhseni and Maarten Minnaard.…
Read more >20 October 2025
Rutgers & Posch advised uniQure in public offering
Rutgers & Posch represented NASDAQ listed uniQure N.V. in a public offering of 6,736,841 ordinary shares at a price of $47.50 per share, as well as pre-funded warrants to purchase 526,316 of its ordinary shares to certain investors. The gross proceeds to the company were approximately $345 million. uniQure is advancing a pipeline of proprietary gene therapies for the treatment of patients with Huntington’s disease, refractory temporal lobe…
Read more >20 October 2025
Rutgers & Posch advises the shareholders of Formdesk
Rutgers & Posch advises the shareholders of Formdesk, a Dutch software company that builds smart web forms via its online platform and links them to underlying systems for organisations, particularly in the semi-public domain, on the sale of Formdesk to Vertical Horizon, a software company that is part of Böschen IT Investments. See this link for more information. The Rutgers & Posch team consisted of Matthijs van den…
Read more >20 October 2025
Rutgers & Posch advises Banyan Software
Rutgers & Posch advises Banyan Software, a leading acquirer and operator of mission-critical software businesses, on the acquisition of Anago, a Netherlands-based provider of planning and resource optimization software that helps public organizations streamline their processes to serve people more efficiently. The team of Rutgers & Posch consisted of Justus Fortuyn, Laura Dingemans, Hanna Steensma, Thomas Been, Maarten Minnaard, Jamie Pellegrom, Ilaha Muhseni and Laetitia Wezenbeek.
Read more >